期刊文献+

二甲双胍和西格列汀治疗2型糖尿病的临床效果 被引量:1

Efficacy of Metformin and Sitagliptin in the Treatment of Type 2 Diabetes
下载PDF
导出
摘要 目的分析2型糖尿病通过西格列汀和二甲双胍治疗的效果。方法研究我院2014年3月~2015年3月接诊的80例2型糖尿病患者,分为对照组和观察组各40例,其中对照组采用二甲双胍,观察组在对照组基础上联合西格列汀治疗,而后分析两组患者在治疗的各效果指标差异。结果在糖化血红蛋白、餐后血糖与空腹血糖的改善情况上,观察组均低于对照组;在治疗不良反应上,观察组为7.5%,对照组为10%。结论 2型糖尿病通过西格列汀和二甲双胍治疗可以达到更有效地血糖控制情况,同时不会提升治疗的不良反应。 Objective To analyze the efficacy of metformin and sitagliptin in the treatment of type 2 diabetes. Methods From March 2014 to March 2015,80 cases of type 2 diabetes were divided into control group and observation group 40 cases,in which the control group with metformin,the observation group were based in joint sitagliptin,then analyzed the effect of two groups of patients in each treatment index difference. Results The improvement in glycated hemoglobin,fasting plasma glucose and postprandial glucose,the observation group were significantly lower than the control group,in the treatment of adverse reactions was 7.5% in the observation group,the control group was 10%. Conclusion Type 2 diabetes through sitagliptin and metformin therapy can achieve more effective glycemic control,while not improve adverse treatment.
作者 李俐 刘力锋
出处 《中国卫生标准管理》 2015年第28期113-114,共2页 China Health Standard Management
关键词 2型糖尿病 二甲双胍 西格列汀 Type 2 diabetes mellitus Metformin Sitagliptin
  • 相关文献

参考文献3

二级参考文献22

  • 1姚军,陈颖丽,胡虹莺,郑宝忠,于桂娜,张俊清,陈静,袁申元,高志红,高燕燕,郭晓蕙,高蕾莉,冯凭,李茵茵,卢纹凯,陈凌,高妍.盐酸吡格列酮治疗2型糖尿病的多中心临床研究[J].中国临床药理学杂志,2005,21(2):95-99. 被引量:16
  • 2Fiona TH Lee. Advances in diabetes therapy in the elderly.J Pharm Pract Res,2009,39( 1 ) ; 63-67. 被引量:1
  • 3Barzilai N,Guo H,Mahoney EM,et al. Efficacy and tolerability ofsitagliptin monotherapy in elderly patients with type 2 diabetes: arandomized, double-blind, placebo-controlled trial. Curr Med ResOpin, 2011,27(5) :1049-1058. 被引量:1
  • 4Mohan V, Yang W, Son HY, et al. Efficacy and safety of sitagiip-tin in the treatment of patients with type 2 diabetes in China,Indi-a,and Korea. Diabetes Res Clin Pract, 2009,83(1) :106-116. 被引量:1
  • 5Amori RE, Lau J,Pittas AG. Efficacy and safety of incretin thera-py in type 2 diabetes : systematic review and meta-analysis. JAMA,2007,298(2):194-206. 被引量:1
  • 6Garg R, Chen W, Pendergrass M. Acute pancreatitis in type 2 dia-betes treated with exenatide or sitagliptin : a retrospective observa-tional pharmacy claims analysis. Diabetes Care, 2010,33 ( 11):2349-2354. 被引量:1
  • 7Scheen AJ. Pharmacokinetics of dipeptidylpeptidase-4 inhibitors.Diabetes Obes Metab, 2010,12(8) :648-658. 被引量:1
  • 8Xu L, Man CD, Charbonnel B, et al. Effect of sitagliptin,a dipep-tidyl peptidase-4 inhibitor, on beta-cell function in patients withtype 2 diabetes: a model-based approach. Diabetes Obes Metab,2008,10(12):1212-1220. 被引量:1
  • 9Del Prato S,Felton AM,Munro N,et al.Improving glucosemanagement:ten steps to get more patients with type 2 diabetes toglycaemic goal[J].Int J Clin Pract,2005,59( 11 ):1345-1355. 被引量:1
  • 10中华医学会糖尿病学分会.《中国2010版2型糖尿病防治指南》[D].北京:2010. 被引量:1

共引文献19

同被引文献22

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部